Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy

Gynecologic Oncology

Volumn 89, Issue 2, 2003, Pages 281-287

  Robson, Mark ^a   Hensley, Martee ^a,b   Barakat, Richard ^a   Brown, Carol ^a   Chi, Dennis ^a   Poynor, Elizabeth ^a   Offit, Kenneth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Oophorectomy; Ovarian cancer; Quality of life; Sexual function

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DYSPAREUNIA; EMOTIONAL STABILITY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OVARIECTOMY; OVARY CARCINOMA; PATIENT INFORMATION; PATIENT SATISFACTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK MANAGEMENT; SEXUAL DYSFUNCTION; SEXUALITY; SYMPTOMATOLOGY; VAGINAL DRYNESS;

EID: 0345352735     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00072-6     Document Type: Article

References (24)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics 2002. CA Cancer J Clin. 52:2002;23-47.
2. Stratton J.F., Pharoah P., Smith S.K., Easton D., Ponder B.A. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 105:1998;493-499.
3. Ford D., Easton D.F., Bishop D.T., Narod S.A., Goldgar D.E. Risks of cancer in BRCA1-mutation carriers Breast Cancer Linkage Consortium . Lancet. 343:1994;692-695.
4. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 91:1999;1310-1316.
5. Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families The Breast Cancer Linkage Consortium . Am J Hum Genet. 62:1998;676-689.
6. Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Edwards B.K. SEER cancer statistics review, 1973-1998. 2001;National Cancer Institute, Bethesda, MD.
7. Burke W., Daly M., Garber J., Botkin J., Kahn M.J., Lynch P., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 277:1997;997-1003.
8. Eisen A., Rebbeck T.R., Wood W.C., Weber B.L. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol. 18:2000;1980-1995.
9. Rebbeck T.R., Lynch H.T., Neuhausen S.L., Narod S.A., Van't Veer L., Garber J.E., et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 346:2002;1616-1622.
10. Kauff N.D., Satagopan J.M., Robson M.E., Scheuer L., Hensley M., Hudis C.A., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 346:2002;1609-1615.
11. Hallowell N. A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psychooncology. 9:2000;486-495.
12. Ware J.E. Jr, Snow K.K., Kosinski M., et al. SF-36 Health Survey: manual and interpretation guide. 1993;MOS Trust, Inc, Boston.
13. Radloff L.S. The CES-D Scale a self-report depression scale for research in the general population . Appl Psychol Measurement. 1:1977;385-401.
14. Devins G.M., Orme C.M. Center for Epidemiological Studies Depression Scale. Keyser D.J., Sweetland R.C. Test critiques. Vol. 2:1985;144-160 Test Corp. of America, Kansas City.
15. Horowitz M., Wilner N., Alvarez W. Impact of Events Scale a measure of subjective stress . Psychosom Med. 41:1979;209-218.
16. Taylor J.F., Rosen R.C., Leilblum S.R. Self-report of female sexual function psychometric evaluation of the Brief Index of Sexual Functioning for Women . Arch Sex Behav. 23:1994;627-642.
17. Syrjala K.L., Schroeder T.C., Abrams J.R., Atkins T.Z., Brown W.S., Sanders J.E., et al. Sexual function measurement and outcomes in cancer survivors and matched controls. J Sex Res. 37:2000;213-225.
18. Hallowell N. You don't want to lose your ovaries because you think I might become a man women's perceptions of prophylactic surgery as a cancer risk management option . Psychooncology. 7:1998;263-275.
19. Meiser B., Tiller K., Gleeson M.A., Andrews L., Robertson G., Tucker K.M. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer. Psychooncology. 9:2000;496-503.
20. Elit L., Esplen M.J., Butler K., Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer. 1:2001;143-148.
21. Fry A., Busby-Earle C., Rush R., Cull A. Prophylactic oophorectomy versus screening psychosocial outcomes in women at increased risk of ovarian cancer . Psychooncology. 10:2001;231-241.
22. Ganz P.A., Desmond K.A., Leedham B., Rowland J.H., Meyerowitz B.E., Belin T.R. Quality of life in long-term, disease-free survivors of breast cancer a follow-up study . J Natl Cancer Inst. 94:2002;39-49.
23. Swisher E.M., Babb S., Whelan A., Mutch D.G., Rader J.S. Prophylactic oophorectomy and ovarian cancer surveillance patient perceptions and satisfaction . J Reprod Med. 46:2001;87-94.
24. Tiller K., Meiser B., Butow P., Clifton M., Thewes B., Friedlander M., Tucker K. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer a prospective study . Gynecol Oncol. 86:2002;212-219.